FDA Inspection 1181591 — LifeStream Blood Bank
The FDA completed an inspection of LifeStream Blood Bank on Oct 11, 2022 in Ontario, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 11, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ontario, CA (United States)